A MODEL FOR INVESTIGATING MICROSCOPIC CHANGES INDUCED BY PROSTAGLANDIN-E(2) IN THE TERM CERVIX

被引:0
|
作者
RAYBURN, WF
LIGHTFOOT, SA
NEWLAND, JR
SMITH, CV
CHRISTENSEN, HD
机构
来源
关键词
CERVIX; PROSTAGLANDIN-E(2); CERVICAL RIPENING; PARTURITION; RABBIT;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purposes of this study were twofold: to examine microscopic changes in the term cervix after prostaglandin E2 (PGE2) using the rabbit model, and to determine the lowest dose of PGE2 that would consistently prompt microscopic change as a basis for future investigation. Methods: Twenty-four New Zealand white rabbits were administered either a placebo or PGE2 gel using hysteroscopic guidance in a blind randomized manner. Twelve served as placebo gel-treated controls-six at 27 days of gestation and six at 29 days, shortly before the anticipated time of early labor. Prostaglandin E2 gel was instilled in the remaining 12 rabbits at day 27 using either a 0.04 mg/kg or 0.08 mg/kg dose which are the human body weight equivalents for cervical ripening. Microscopic changes in the cervix were evaluated by two pathologists in a blind manner, then compared using analyses of variance testing. Results: Compared with the day 27 control group, microscopic changes in the day 29 control group were more apparent for the presence of submucosal edema (P = 0.03), dissolution of collagen bundles (P = 0.01), and presence of multinucleated histiocytes (P = 0.001). Microscopic changes in the cervix after use of the higher prostaglandin E2 dose on day 27 were more apparent than after using the lower dose and were indistinguishable from the day 29 controls. Conclusion: Using the gravid rabbit near term, PGE2 applied near the cervical os stimulated in a dose-dependent manner the same microscopic changes in the cervical connective tissue as those found during early labor. These findings using the 0.08 mg/kg dose should serve in future investigations to answer clinical questions pertaining to cervical ripening.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 50 条
  • [1] DIURETIC INDUCED CHANGES IN RENAL PROSTAGLANDIN-E EXCRETION
    PATAK, R
    FADEM, S
    ROSENBLATT, S
    LIFSCHITZ, M
    STEIN, J
    CLINICAL RESEARCH, 1978, 26 (01): : A42 - A42
  • [2] IMMUNOELECTRON MICROSCOPIC DEMONSTRATION OF PROSTAGLANDIN-E IN RHEUMATOID SYNOVIUM
    SHIOZAWA, S
    WILLIAMS, RC
    ZIFF, M
    ARTHRITIS AND RHEUMATISM, 1982, 25 (06): : 685 - 693
  • [3] PROSTAGLANDIN E(2)-INDUCED RIPENING OF THE HUMAN CERVIX INVOLVES CHANGES IN PROTEOGLYCAN METABOLISM
    NORMAN, M
    EKMAN, G
    MALMSTROM, A
    OBSTETRICS AND GYNECOLOGY, 1993, 82 (06): : 1013 - 1020
  • [4] PLASMA PROSTAGLANDIN-E AND F2-ALPHA IN TERM INFANTS
    MANCHANDIA, MR
    MICHELAKIS, AM
    KARNA, P
    DOLANSKI, EA
    PEDIATRIC RESEARCH, 1978, 12 (04) : 530 - 530
  • [5] PROSTAGLANDIN-E2-INDUCED CHANGES IN THE DISTRIBUTION OF GLYCOSAMINOGLYCANS IN THE ISOLATED RAT UTERINE CERVIX
    CABROL, D
    DUBOIS, P
    SEDBON, E
    DALLOT, E
    LEGAGNEUX, J
    AMICHOT, G
    CEDARD, L
    SUREAU, C
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 26 (04): : 359 - 365
  • [6] CHANGES IN PROSTAGLANDIN-E EXCRETION INDUCED WITH LINOLEATES AND DIHOMO-GAMMA-LINOLENIC ACID
    KIRTLAND, SJ
    COWAN, I
    HOOPER, H
    SHAWYER, CR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1987, 15 (03) : 424 - 425
  • [7] STUDIES OF MECHANISM OF PROSTAGLANDIN-E (PGE) INDUCED NATRIURESIS
    BAY, WH
    FERRIS, TF
    CLINICAL RESEARCH, 1975, 23 (03): : A355 - A355
  • [8] PROSTAGLANDIN-E(2) IN EQUINE JOINT DISEASE
    MAY, SA
    HOOKE, RE
    PEREMANS, KY
    VERSCHOOTEN, F
    LEES, P
    VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 1994, 63 (06): : 187 - 191
  • [10] PROSTAGLANDIN-E(2) ALLEVIATES CYCLOSPORINE-A-INDUCED BONE LOSS IN THE RAT
    KATZ, IA
    JEE, WSS
    JOFFE, II
    STEIN, B
    TAKIZAWA, M
    JACOBS, TW
    SETTERBERG, R
    LIN, BY
    TANG, LY
    KE, HZ
    ZENG, QQ
    BERLIN, J
    EPSTEIN, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 (10) : 1191 - 1200